PH23620A - Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon - Google Patents

Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon

Info

Publication number
PH23620A
PH23620A PH34710A PH34710A PH23620A PH 23620 A PH23620 A PH 23620A PH 34710 A PH34710 A PH 34710A PH 34710 A PH34710 A PH 34710A PH 23620 A PH23620 A PH 23620A
Authority
PH
Philippines
Prior art keywords
antibiotic
aglycon
factor
acylaminoglucuronyl
acylaminoglucuronyl aglycon
Prior art date
Application number
PH34710A
Other languages
English (en)
Inventor
Enrico Selva
Ernesto Riva
Giovanni Cassani
Francesco Parenti
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of PH23620A publication Critical patent/PH23620A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH34710A 1986-04-11 1987-01-12 Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon PH23620A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868608809A GB8608809D0 (en) 1986-04-11 1986-04-11 Antibiotic

Publications (1)

Publication Number Publication Date
PH23620A true PH23620A (en) 1989-09-11

Family

ID=10596024

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34710A PH23620A (en) 1986-04-11 1987-01-12 Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon

Country Status (22)

Country Link
US (1) US4868171A (de)
EP (1) EP0240609B1 (de)
JP (1) JPH0759593B2 (de)
KR (2) KR950010461B1 (de)
CN (1) CN1033043C (de)
AT (1) ATE70069T1 (de)
AU (1) AU601706B2 (de)
DE (1) DE3682767D1 (de)
DK (1) DK167770B1 (de)
ES (1) ES2040207T3 (de)
FI (1) FI86307C (de)
GB (1) GB8608809D0 (de)
GR (1) GR3003443T3 (de)
HU (1) HU196229B (de)
IE (1) IE59523B1 (de)
IL (1) IL81106A (de)
MY (1) MY101178A (de)
NO (1) NO172121C (de)
NZ (1) NZ218789A (de)
PH (1) PH23620A (de)
PT (1) PT84029B (de)
ZA (1) ZA869713B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
ES2084595T3 (es) * 1988-12-27 1996-05-16 Lepetit Spa Procedimiento quimico mejorado para preparar el antibiotico l/17392 (desglucoteicoplanina) y sus sales.
HUT63860A (en) * 1990-12-05 1993-10-28 Lepetit Spa Process for producing 39-decarboxy-38-(hydroxymethyl) derivatives of teikoplanin antibiotics
HU210665B (en) 1991-03-27 1995-06-28 Lepetit Spa Process for producing ester derivatives of the antibiotic a 40926 and pharmaceutical compositions containing them as active component
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
UA41283C2 (uk) * 1991-07-29 2001-09-17 Біосерч Італіа С.П.А. Похідні антибіотику а 40926 та способи їх одержання
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
ES2224173T3 (es) * 1995-07-05 2005-03-01 Aventis Bulk S.P.A. Purificacion de antibioticos dalbaheptidos por enfoque isoelectrico.
EP0912604B1 (de) 1996-04-23 2001-11-14 Biosearch Italia S.p.A. Chemisches Verfahren zur Herstellung von Amidderivaten von A 40926 Antibiotikum
HUE041133T2 (hu) 2002-11-18 2019-05-28 Vicuron Pharmaceuticals Llc Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
CN101851277B (zh) * 2009-03-12 2012-10-03 成都雅途生物技术有限公司 一种道古霉素关键中间体a40926 bo组分的纯化制备方法
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法
CN110105435B (zh) * 2019-05-08 2023-12-08 宜昌东阳光生化制药有限公司 一种生产a40926的发酵培养基和发酵方法
CN112625925B (zh) * 2021-01-08 2022-04-19 浙江大学 一种达巴万星前体a40926b0高产菌株及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229888A1 (es) * 1982-03-24 1983-12-30 Lilly Co Eli Procedimiento para preparar el complejo antibiotico a41030 y sus factores a,b,c,d,e,f, y g
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4521335A (en) * 1983-07-13 1985-06-04 Smithkline Beckman Corporation Aglycone and pseudo-aglycones of the AAD 216 antibiotics
AU579120B2 (en) * 1983-12-16 1988-11-17 Gruppo Lepetit S.P.A. Chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
HU196229B (en) 1988-10-28
NZ218789A (en) 1990-09-26
IL81106A0 (en) 1987-03-31
KR960010557B1 (ko) 1996-08-02
IL81106A (en) 1992-07-15
JPS62242699A (ja) 1987-10-23
FI865320A0 (fi) 1986-12-29
EP0240609A2 (de) 1987-10-14
DE3682767D1 (de) 1992-01-16
ES2040207T3 (es) 1993-10-16
FI86307C (fi) 1992-08-10
US4868171A (en) 1989-09-19
EP0240609A3 (en) 1988-07-27
GB8608809D0 (en) 1986-05-14
JPH0759593B2 (ja) 1995-06-28
NO172121C (no) 1993-06-09
FI865320A (fi) 1987-10-12
HUT43869A (en) 1987-12-28
DK617286A (da) 1987-10-12
PT84029B (pt) 1989-01-17
GR3003443T3 (en) 1993-02-17
AU601706B2 (en) 1990-09-20
DK167770B1 (da) 1993-12-13
FI86307B (fi) 1992-04-30
KR890002231A (ko) 1989-04-08
PT84029A (en) 1987-01-01
MY101178A (en) 1991-07-31
KR870010194A (ko) 1987-11-30
ATE70069T1 (de) 1991-12-15
IE59523B1 (en) 1994-03-09
CN86108977A (zh) 1988-04-27
NO865323L (no) 1987-10-12
DK617286D0 (da) 1986-12-19
NO172121B (no) 1993-03-01
CN1033043C (zh) 1996-10-16
IE863382L (en) 1987-10-11
KR950010461B1 (ko) 1995-09-18
ZA869713B (en) 1987-12-30
EP0240609B1 (de) 1991-12-04
AU6688386A (en) 1987-10-15

Similar Documents

Publication Publication Date Title
GR3003443T3 (en) Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon
IE863381L (en) Antibiotics
PT85885A (en) Process for preparing novel de-acyl a 40926 antibiotics
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
GR3015899T3 (en) Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T.
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms